A Financial Times Service
China Confidential - Premium Investment Insight

Best of Chinese Commentators

China’s toxic drug capsule scandal

19 April 2012

China’s drug regulator halted sales of 13 drugs on April 15 that use capsules allegedly made from industrial gelatin that contains excessive levels of toxic metal chromium, a potential cause of cancer. The 13 drugs under suspension were all made by Chinese pharmaceutical companies that buy plastic drug capsules produced by small manufacturers in China’s eastern Zhejiang province. The drug regulator also asked local authorities to carry out inspections of local capsule manufacturers. So far, police have reportedly detained 22 people who allegedly produced and sold the capsules.

RENMINBI COMPASS

Renminbi Compass reflects key changes in the renminbi-denominated investment environment.

Providing research coverage on asset classes as diverse as chengtou bonds, dim sum bonds, real estate, trust products, underground banking, art and antiques, as well as its traditional equity fund research.

Renminbi Compass provides orientation for investors navigating the expanding universe of renminbi asset classes.